131 related articles for article (PubMed ID: 35848073)
1. Current evidence for pharmacologic therapy following stage 1 palliation for single ventricle congenital heart disease.
Broberg MCG; Cheifetz IM; Plummer ST
Expert Rev Cardiovasc Ther; 2022 Aug; 20(8):627-636. PubMed ID: 35848073
[TBL] [Abstract][Full Text] [Related]
2. Association of Digoxin With Interstage Mortality: Results From the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Use Dataset.
Oster ME; Kelleman M; McCracken C; Ohye RG; Mahle WT
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26764412
[TBL] [Abstract][Full Text] [Related]
3. Impact of pharmacotherapy on interstage outcomes in single ventricle infants.
Moffett BS; Mattamal R; Ocampo EC; Petit CJ
Congenit Heart Dis; 2011; 6(4):286-93. PubMed ID: 21696551
[TBL] [Abstract][Full Text] [Related]
4. Association of Digoxin Use With Transplant-Free Interstage Survival in Infants Palliated With a Stage 1 Hybrid Procedure.
Reddy RK; Zyblewski SC; Chowdhury SM; Godown J; Bradley SM; Brown DW; Duncan RK; Brown TN; Bates KE; Minich LL; Costello JM
J Am Heart Assoc; 2023 Oct; 12(20):e029521. PubMed ID: 37804192
[TBL] [Abstract][Full Text] [Related]
5. Association Between Digoxin Use and Cardiac Function in Infants With Single-Ventricle Congenital Heart Disease During the Interstage Period.
Kumar KR; Flair A; Thompson EJ; Zimmerman KO; Andersen ND; Hill KD; Hornik CP
Pediatr Crit Care Med; 2022 Jun; 23(6):453-463. PubMed ID: 35404313
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitors and interstage failure in infants with hypoplastic left heart syndrome.
Yimgang DP; Sorkin JD; Evans CF; Abraham DS; Rosenthal GL
Congenit Heart Dis; 2018 Jul; 13(4):533-540. PubMed ID: 30019493
[TBL] [Abstract][Full Text] [Related]
7. Effect of feeding modality on interstage growth after stage I palliation: a report from the National Pediatric Cardiology Quality Improvement Collaborative.
Hill GD; Hehir DA; Bartz PJ; Rudd NA; Frommelt MA; Slicker J; Tanem J; Frontier K; Xiang Q; Wang T; Tweddell JS; Ghanayem NS
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1534-9. PubMed ID: 24607373
[TBL] [Abstract][Full Text] [Related]
8. Digoxin Use in Infants with Single Ventricle Physiology: Secondary Analysis of the Pediatric Heart Network Infant Single Ventricle Trial Public Use Dataset.
Truong DT; Menon SC; Lambert LM; Burch PT; Sheng X; Minich LL; Williams RV
Pediatr Cardiol; 2018 Aug; 39(6):1200-1209. PubMed ID: 29799077
[TBL] [Abstract][Full Text] [Related]
9. Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial.
Ghanayem NS; Allen KR; Tabbutt S; Atz AM; Clabby ML; Cooper DS; Eghtesady P; Frommelt PC; Gruber PJ; Hill KD; Kaltman JR; Laussen PC; Lewis AB; Lurito KJ; Minich LL; Ohye RG; Schonbeck JV; Schwartz SM; Singh RK; Goldberg CS;
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):896-906. PubMed ID: 22795436
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning to Predict Interstage Mortality Following Single Ventricle Palliation: A NPC-QIC Database Analysis.
Sunthankar SD; Zhao J; Wei WQ; Hill GD; Parra DA; Kohl K; McCoy A; Jayaram NM; Godown J
Pediatr Cardiol; 2023 Aug; 44(6):1242-1250. PubMed ID: 36820914
[TBL] [Abstract][Full Text] [Related]
11. The role of home monitoring in interstage management of infants following the Norwood procedure.
Ugonabo N; Hirsch-Romano JC; Uzark K
World J Pediatr Congenit Heart Surg; 2015 Apr; 6(2):266-73. PubMed ID: 25870346
[TBL] [Abstract][Full Text] [Related]
12. Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease.
Brown DW; Mangeot C; Anderson JB; Peterson LE; King EC; Lihn SL; Neish SR; Fleishman C; Phelps C; Hanke S; Beekman RH; Lannon CM;
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26755552
[TBL] [Abstract][Full Text] [Related]
13. Interstage outcomes in single ventricle patients undergoing hybrid stage 1 palliation.
Simsic JM; Phelps C; Kirchner K; Carpenito KR; Allen R; Miller-Tate H; Texter K; Galantowicz M
Congenit Heart Dis; 2018 Sep; 13(5):757-763. PubMed ID: 30022622
[TBL] [Abstract][Full Text] [Related]
14. A word on netting of angiotensin-converting enzyme inhibitor therapy in hypoplastic left heart syndrome following stage-I.
Schranz D; Krasemann T
Cardiol Young; 2021 Aug; 31(8):1323-1326. PubMed ID: 34318741
[TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacotherapy on interstage mortality and weight gain in children with single ventricle.
Ghelani SJ; Spurney CF; Martin GR; Cross RR
Congenit Heart Dis; 2013; 8(3):219-27. PubMed ID: 23157489
[TBL] [Abstract][Full Text] [Related]
16. Variability of antithrombotics use in patients with hypoplastic left heart syndrome and its variants following first- and second-stage palliation surgery: a national report using the National Pediatric Cardiology Quality Improvement Collaborative registry.
Ramachandran P; King E; Nebbia A; Beekman RH; Anderson JB
Cardiol Young; 2017 May; 27(4):731-738. PubMed ID: 27981915
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC-QIC Registry.
Hansen JE; Brown DW; Hanke SP; Bates KE; Tweddell JS; Hill G; Anderson JB
J Am Heart Assoc; 2020 May; 9(10):e014823. PubMed ID: 32384002
[TBL] [Abstract][Full Text] [Related]
18. Association of a Home Monitoring Program With Interstage and Stage 2 Outcomes.
Gardner MM; Mercer-Rosa L; Faerber J; DiLorenzo MP; Bates KE; Stagg A; Natarajan SS; Szwast A; Fuller S; Mascio CE; Fleck D; Torowicz DL; Giglia TM; Rome JJ; Ravishankar C
J Am Heart Assoc; 2019 May; 8(10):e010783. PubMed ID: 31112448
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of multistage palliation of infants with functional single ventricle and heterotaxy syndrome.
Alsoufi B; McCracken C; Schlosser B; Sachdeva R; Well A; Kogon B; Border W; Kanter K
J Thorac Cardiovasc Surg; 2016 May; 151(5):1369-77.e2. PubMed ID: 27085618
[TBL] [Abstract][Full Text] [Related]
20. Impact of Digoxin Use on Interstage Outcomes of Single Ventricle Heart Disease (From a NPC-QIC Registry Analysis).
Klausner RE; Parra D; Kohl K; Brown T; Hill GD; Minich L; Godown J
Am J Cardiol; 2021 Sep; 154():99-105. PubMed ID: 34238447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
